This document encourages women with the KRAS-variant gene mutation, which is associated with a 20% increased risk of breast cancer, to enroll in a MiraKind study to help researchers find effective treatments and lifestyle options for prevention and cure. It also notes that these women may have an increased risk of a second independent cancer, so the study aims to help learn more about cancer risks associated with this newly discovered inherited gene mutation.

1. Awareness is great, but
ENROLL in a MiraKind
study and help find
answers for the 20%
of women with breast
cancer who carry the
KRAS-variant gene
mutation.
HELP researchers find
treatment and lifestyle
options that will make
significant strides
towards prevention
and cure for KRAS-variant
women.
THIS OCTOBER . . .
LEARN about the
increased risk for a
second, independent
cancer that is associated
with this newly found
inherited gene
mutation.
ACTION is better.
MiraKind.org